Hair News

Cannabis Reclassification Means Some Coverage For Medicare Recipients

Rubenhair Latvia
3 min read
09.01.2026
Cannabis Reclassification Means Some Coverage For Medicare Recipients
**Breaking News: Potential Changes to Cannabis Classification May Bring Relief to Medicare Recipients**

The White House has issued a directive to expedite the reclassification of cannabis under federal law, which may lead to certain benefits for Medicare recipients. This development could have significant implications for older adults who use cannabis-based products.

Cannabis refers to a group of plants that includes both marijuana and hemp. While "marijuana" has historically been associated with concerns about addiction, the term "cannabis" is often used when discussing marijuana-related topics due to its broader meaning.

As part of this directive, President Donald Trump has ordered Justice Department officials to speed up the approval process for reclassifying marijuana from a Schedule I drug to a Schedule III drug. This change would classify cannabis as a compound with "a moderate to low potential for physical and psychological dependence," rather than a substance with "no currently accepted medical use and a high potential for abuse."

While this reclassification is still in the process of being implemented, it may have significant benefits for older adults who are covered under Medicare. According to experts, the change could lead to increased access to cannabis-based products and potentially allow qualifying Medicare recipients to be reimbursed by Medicare for up to $500 per year for certain CBD-based products.

What Does This Mean for Older Adults on Medicare?

The proposed changes may provide financial relief for older adults who use cannabis-based products. Under the new guidelines, older adults on Medicare may be able to access medical marijuana if deemed necessary and recommended by a medical doctor. Additionally, qualifying Medicare recipients may be eligible for reimbursement of up to $500 per year for certain CBD-based products.

It's essential to note that these benefits may not be available under Medicare Advantage (Part C) plans. We recommend checking with your specific insurance provider for more information.

Expert Insights

"The potential reimbursement of up to $500 per year for qualifying CBD-based products could be a significant boon for older adults who are using these products," said Sherry Yafai, MD, an emergency medicine physician and founder and medical director of The RELEAF Institute in Los Angeles.

Learn more about hair transplant at Rubenhair clinic.

Get a Free Consultation

Consult with our specialists about FUE procedure, PRP therapy or hair transplant.

Do you have questions?

Contact us and get a free consultation about hair transplantation

+371 267 777 76